Utilization of PS matching corrected the baseline differences for disease state and tumor burdens within the two groups and revealed the inefficacy of NHT on decreasing RM positivity, BCR, and OS, which was contrary to previous reports [2, 10, 11], and which was accorded to the current EAU guideline of PC [3]. This evidence concerns the gene BCR and neoplasm.